Clinical development news in brief
Recent developments in the clinical research sector include an acquisition by Canada’s Algorithme, a Dutch CRO looking to push into the North American market, and a £20m boost for UK clinical research.
Archives for September 3, 2008
Caliper measures up kinase profiling
Caliper Life Sciences has launched two new kinase profiling services as well as new assay kits that aim to provide researchers with a better understanding of their kinase inhibitor drug candidates.
Loramyc’s excipient shows BioAlliance the whey
Drug delivery specialist BioAlliance Pharma says that its decision to focus on the oncology and infectious disease markets helped it reduce its half-year 2008 losses.
Cost of drug licensing on the wane, says Lehman Bros
Growth in licensing deals between large drugmakers companies and their smaller, research-based counterparts continued apace in 2007, but the average total value of each deal has started to fall.
SAFC Pharma to get even bigger in high-potency APIs
US fine chemical company Sigma-Aldrich said this morning that subsidiary SAFC Pharma has kicked off a $30m expansion plan for its active high-potency pharmaceutical ingredient (API) manufacturing facility in Madison, Wisconsin.